CITIUS ONCOLOGY, INC. (CTOR) (CIK 0001851484) (CTOR)
Activity window: Nov. 12, 2025 to Nov. 11, 2026
Export this company’s current score, component values, matched signals, and scoring date as a one-row CSV snapshot.
The total combines correspondence volume, AI sentiment, matched keywords and signals, and a weighted 8-K adjustment, capped at 10.0. This is the 365-day v1 snapshot. Computed: Nov. 11, 2026. Latest filing activity: Jun. 3, 2026. These dates describe different events.
| Date | Form | Sentiment | Urgency | Summary | Open |
|---|---|---|---|---|---|
| Jun. 3, 2026 | UPLOAD | Neutral/Informational | Low | The SEC has communicated to Citius Oncology, Inc. that it will not review the company's registration statement filed on May 29, 2026. The letter emphasizes that the responsibility… | Read Filing EDGAR |
| Jun. 3, 2026 | CORRESP | Neutral/Informational | Moderate | Citius Oncology, Inc. has submitted a request to the U.S. Securities and Exchange Commission (SEC) to accelerate the effective date of their registration statement filed on May 29… | Read Filing EDGAR |
| Jan. 9, 2026 | UPLOAD | Neutral/Informational | Low | The SEC has communicated to Citius Oncology, Inc. that they will not review the company's registration statement filed on January 5, 2026. The letter emphasizes the company's resp… | Read Filing EDGAR |
| Jan. 9, 2026 | CORRESP | Neutral/Informational | Moderate | Citius Oncology, Inc. has submitted a request to the U.S. Securities and Exchange Commission (SEC) for the acceleration of the effective date of their registration statement filed… | Read Filing EDGAR |